Literature DB >> 7929218

Intracellular trapping of a cytoplasmic folding intermediate of the phage P22 tailspike using iodoacetamide.

S K Sather1, J King.   

Abstract

Critical steps in polypeptide chain folding within the bacterial cytoplasm have been difficult to identify. Salmonella cells infected with temperature-sensitive folding mutants of the P22 tailspike protein at restrictive temperature accumulated a metastable folding intermediate with a half-life of 6 min at 39 degrees C. The native trimeric tailspike contains 24 buried cysteines (8/chain) but neither disulfide bonds nor active site cysteines. Eighteen of the 24 cysteines are involved in strong hydrogen bonds (Thomas, G. J., Jr., Becka, R., Sargent, D., Yu, M.-H., and King, J. (1990) Biochemistry 29, 4181-4187). Cyanide and iodoacetamide prevented the folding and association of the restrictive temperature folding intermediate to the native state after shift to permissive temperature. The cytoplasmic folding intermediate was covalently modified by iodoacetamide within infected cells. Chains which had reacted with iodoacetamide were unable to proceed through the folding pathway. Iodoacetamide also reacted with a folding intermediate during the refolding of purified tailspike chains in vitro, inhibiting further folding. No reaction occurred with native tailspike in vivo or in vitro. The target residues in the intermediates were in the carboxyl terminus of the chain and may be a unique set of cysteine residues that are activated during protein folding, but not in the native state.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  C-terminal hydrophobic interactions play a critical role in oligomeric assembly of the P22 tailspike trimer.

Authors:  Matthew J Gage; Anne Skaja Robinson
Journal:  Protein Sci       Date:  2003-12       Impact factor: 6.725

2.  Pressure dissociation studies provide insight into oligomerization competence of temperature-sensitive folding mutants of P22 tailspike.

Authors:  Brian G Lefebvre; Noelle K Comolli; Matthew J Gage; Anne Skaja Robinson
Journal:  Protein Sci       Date:  2004-05-07       Impact factor: 6.725

3.  Dissociation of intermolecular disulfide bonds in P22 tailspike protein intermediates in the presence of SDS.

Authors:  Junghwa Kim; Anne Skaja Robinson
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

4.  Cold rescue of the thermolabile tailspike intermediate at the junction between productive folding and off-pathway aggregation.

Authors:  S D Betts; J King
Journal:  Protein Sci       Date:  1998-07       Impact factor: 6.725

5.  Conformation of P22 tailspike folding and aggregation intermediates probed by monoclonal antibodies.

Authors:  M A Speed; T Morshead; D I Wang; J King
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

Review 6.  Thermolabile folding intermediates: inclusion body precursors and chaperonin substrates.

Authors:  J King; C Haase-Pettingell; A S Robinson; M Speed; A Mitraki
Journal:  FASEB J       Date:  1996-01       Impact factor: 5.191

7.  Role for cysteine residues in the in vivo folding and assembly of the phage P22 tailspike.

Authors:  C Haase-Pettingell; S Betts; S W Raso; L Stuart; A Robinson; J King
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

8.  Phage P22 tailspike protein: removal of head-binding domain unmasks effects of folding mutations on native-state thermal stability.

Authors:  S Miller; B Schuler; R Seckler
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

9.  Cotranslational folding promotes beta-helix formation and avoids aggregation in vivo.

Authors:  Michael S Evans; Ian M Sander; Patricia L Clark
Journal:  J Mol Biol       Date:  2008-07-22       Impact factor: 5.469

10.  Nonnative interactions between cysteines direct productive assembly of P22 tailspike protein.

Authors:  Brenda L Danek; Anne Skaja Robinson
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.